The Effect on Patients’ Visual Acuity and Grade, Secondary to Non-Attendance at Treatment Centers, Post Referral from Diabetic RetinaScreen Ireland

Background Patient non-attendance following referral to hospital is a significant challenge, in particular, for persons with diabetes. Aim We sought to determine the impact on both visual acuity and the subsequent follow-up retinopathy grade of patients when they fail to attend Diabetic Retinopathy Treatment (DRT) Centers following referral from Diabetic RetinaScreen (DRS). Methods A retrospective analysis of patients discharged from DRT due to multiple consecutive missed appointments between January 2016 and June 2021. Patients discharged for non-attendance were compared with patients discharged from completed treatment. Results Of the 24,945 NEC patients referred to DRT, 5900 (24%) and 9345 (37%) were discharged back to DRS due to non-attendance and completed treatment, respectively. Those discharged for non-attendance were younger (60.7 v 63.4, p < 0.001) and had higher proportions of males (67% v 63%, p < 0.001) and people with type 1 diabetes (27% v 18%, p < 0.001). After attending rescreening after discharge, those discharged for non-attendance were significantly more likely to have a worsening of DR grade (26% v 8%, p < 0.001). Conclusion Despite being notified that further investigation (with possible treatment) was required post DRS, many diabetic patients failed to attend for further management of their eye care in DRT. These patients had worse visual outcomes compared to those that attended. Improved patient education and communication are required to mitigate against the consequences of non-attendance.

[1]  H. Ashrafian,et al.  Characterising the nationwide burden and predictors of unkept outpatient appointments in the National Health Service in England: A cohort study using a machine learning approach , 2021, PLoS medicine.

[2]  Stephen R. Kelly,et al.  Factors associated with non-attendance in the Irish national diabetic retinopathy screening programme (INDEAR study report no. 2) , 2021, Acta Diabetologica.

[3]  M. Cahill,et al.  Irish National Diabetic RetinaScreen Programme: report on five rounds of retinopathy screening and screen-positive referrals. (INDEAR study report no. 1) , 2020, British Journal of Ophthalmology.

[4]  James G. Lathe,et al.  Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT , 2020, Diabetologia.

[5]  P. Keane,et al.  A virtual-clinic pathway for patients referred from a national diabetes eye screening programme reduces service demands whilst maintaining quality of care , 2020, Eye.

[6]  David Delgado-Gómez,et al.  A Probabilistic Patient Scheduling Model with Time Variable Slots , 2020, Comput. Math. Methods Medicine.

[7]  J. Shaw,et al.  Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. , 2019, Diabetes research and clinical practice.

[8]  P. Kearney,et al.  Understanding the uptake of a national retinopathy screening programme: An audit of people with diabetes in two large primary care centres , 2019, HRB open research.

[9]  K. Houlind,et al.  Rate and predictors for non-attendance of patients undergoing hospital outpatient treatment for chronic diseases: a register-based cohort study , 2019, BMC Health Services Research.

[10]  D. Coakley,et al.  The effect of geodemographic factors on the attendance rates at a regional diabetic retinopathy treatment centre , 2019, Irish Journal of Medical Science (1971 -).

[11]  V. Chaudhary,et al.  Does patient education improve compliance to routine diabetic retinopathy screening? , 2018, Journal of telemedicine and telecare.

[12]  P. Scanlon The English National Screening Programme for diabetic retinopathy 2003–2016 , 2017, Acta Diabetologica.

[13]  C. Owsley,et al.  Patients' Adherence to Recommended Follow-up Eye Care After Diabetic Retinopathy Screening in a Publicly Funded County Clinic and Factors Associated With Follow-up Eye Care Use. , 2016, JAMA ophthalmology.

[14]  I. Stratton,et al.  System-level and patient-level explanations for non-attendance at diabetic retinopathy screening in Sutton and Merton (London, UK): a qualitative analysis of a service evaluation , 2016, BMJ Open.

[15]  A. Forster,et al.  Non-attendance at diabetic eye screening and risk of sight-threatening diabetic retinopathy: a population-based cohort study , 2013, Diabetologia.

[16]  A. Staines,et al.  Factors that influence the patient uptake of diabetic retinopathy screening , 2008, Irish journal of medical science.

[17]  G. M. Zoega,et al.  Screening compliance and visual outcome in diabetes. , 2005, Acta ophthalmologica Scandinavica.

[18]  M. C. Leske,et al.  Patterns of adherence to diabetes vision care guidelines: baseline findings from the Diabetic Retinopathy Awareness Program. , 2001, Ophthalmology.

[19]  Marilyn James,et al.  Cost effectiveness analysis of screening for sight threatening diabetic eye disease , 2000, BMJ : British Medical Journal.

[20]  G. Brown,et al.  Utility values and diabetic retinopathy. , 1999, American journal of ophthalmology.

[21]  R. Halbert,et al.  Effect of multiple patient reminders in improving diabetic retinopathy screening. A randomized trial. , 1999, Diabetes care.

[22]  S. Griffin,et al.  Lost to follow‐up: the problem of defaulters from diabetes clinics , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[23]  T. Sano,et al.  [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.